Dr. Matthew Frigault’s Breakthroughs with Cell Therapies
Dr. Matthew Frigault, the inaugural Ranelli Scholar™, isn’t just pursuing safer and better cancer treatments via cellular therapies, he’s pursuing a cure.
“In oncology, we’re always afraid to say the word ‘cured.’ We always say we can’t find evidence of disease,” said Dr. Frigault. “Going back to the first discussions I had with people about cell therapy, the tone was that we’re going for cure. Having that kind of starting philosophy is powerful.”
In addition to being a Ranelli Scholar, Frigault is the clinical director of the Cellular Therapy Service at MassGen and an associate professor at Harvard medicine.
Read the full article, “How Cell Therapies are Breaking the Cancer Treatment Mold,” on the MassGen website.
To learn more and donate to the Ranelli Cancer Innovation Scholar™ fund, visit Team Up to Cure Cancer™.